Pricing of forthcoming therapies for hepatitis C in Europe : beyond cost-effectiveness?
Year of publication: |
2015
|
---|---|
Authors: | Van de Vooren, Katelijne ; Curto, Alessandro ; Garattini, Livio |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 16.2015, 4, p. 341-345
|
Subject: | EU-Staaten | EU countries | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Europa | Europe |
-
Coverage with evidence development for medical devices in Europe : can practice meet theory?
Drummond, Michael F., (2022)
-
Wätzold, Frank, (2004)
-
Lee, Dawn C., (2014)
- More ...
-
Western European Markets for biosimilar and generic drugs : worth differentiating : Editorial
Garattini, Livio, (2015)
-
Italian risk-sharing agreements on drugs : are they worthwhile?
Garattini, Livio, (2015)
-
Editorial: market approval for drugs in the EU : time to change direction?
Curto, Alessandro, (2017)
- More ...